Prediction of Plasma ctDNA Fraction and Prognostic Implications of Liquid Biopsy in Advanced Prostate Cancer - Beyond ...
Clinical outcomes for metastatic castration-resistant prostate cancer (mCRPC) remain highly heterogeneous despite incremental improvements in survival.1 However, current strategies to estimate life expectancy largely rely on only weakly informative …